Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Analyzing the National Lung Cancer Audit (NLCA)

Matthew Hatton • 30 Jan 2020
BTOG 2020
Lung Cancer

Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, University of Sheffield, Sheffield, UK, discusses the focus on data from the National Lung Cancer Audit, which suggests that most stage III patients are not receiving the standard of care treatment. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from Matthew Hatton

1:00
Exploring ILD drugs in lung cancer: research gaps and opportunities
Matthew Hatton • 19 Apr 2024
0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
1:44
Managing lung cancer patients with ILD: the oncology perspective
Matthew Hatton • 18 Apr 2024
1:08
Personalized treatment planning for lung cancer with interstitial lung disease
Matthew Hatton • 19 Apr 2024

Related Videos

0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
2:26
Targeting KRAS mutations in lung cancer
Thomas Newsom-Davis • 18 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals